Albumin (as Excipient) Market Research Report from 2023 forecast to 2029, by Manufacturers, Regions, Type and Application

The global Albumin (as Excipient) market size was valued at USD 4466.1 million in 2022 and is forecast to a readjusted size of USD 6643.7 million by 2029 with a CAGR of 5.8% during review period.

Albumin is a water-soluble globular protein produced in the liver. It accounts for 50% of blood plasma proteins. These play a vital role in regulating blood volume and act as transporters for molecules such as few hormones, bile salts, and ions. Albumin is commonly used as blood volumizer in rare diseases, burns, shocks, liver conditions, and other blood loss trauma and surgeries.

The industry's leading manufacturers are Grifols, CSL and Takeda, which accounted for 20.39%, 15.19% and 14.36% of global revenues in 2019. By region, Asia-Pacific is the largest consumption market of Albumin (as Excipient), with its sales volume at 70.83%.

This report is a detailed and comprehensive analysis for global Albumin (as Excipient) market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.

Key Features:

Global Albumin (as Excipient) market size and forecasts, in consumption value ($ Million), sales quantity (MT), and average selling prices (USD/Kg), 2018-2029
Global Albumin (as Excipient) market size and forecasts by region and country, in consumption value ($ Million), sales quantity (MT), and average selling prices (USD/Kg), 2018-2029
Global Albumin (as Excipient) market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (MT), and average selling prices (USD/Kg), 2018-2029
Global Albumin (as Excipient) market shares of main players, shipments in revenue ($ Million), sales quantity (MT), and ASP (USD/Kg), 2018-2023

The Primary Objectives in This Report Are:

To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Albumin (as Excipient)
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace

This report profiles key players in the global Albumin (as Excipient) market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.

   CSL
   Grifols
   Takeda
   Octapharma
   Hualan Bio
   CBPO
   Shanghai RAAS
   Kedrion
   LFB Group
   Albumedix
   Biotest
   Merck
   Ventria (InVitria)
   HiMedia

   Human Serum Albumin
   Recombinant Albumin

   Cell Culture Media
   Medical Supplements
   Therapeutics

   North America (United States, Canada and Mexico)
   Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
   Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
   South America (Brazil, Argentina, Colombia, and Rest of South America)
   Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)

What are the strengths of the Albumin (as Excipient) Market 2025?

Albumin is a highly stable excipient that enhances the solubility and stability of various drug formulations, making it indispensable in biopharmaceutical development. Its biocompatibility and ability to improve drug delivery systems increase its demand in the pharmaceutical industry.

What are the weaknesses of the Albumin (as Excipient) Market 2025?

The high cost of purified albumin limits its widespread use, particularly in price-sensitive markets. Additionally, the potential for immunogenic reactions in some individuals can create regulatory challenges, hindering its broader adoption.

What are the opportunities in the Albumin (as Excipient) Market 2025?

There is a growing demand for biologic drugs and gene therapies, which significantly boosts the need for albumin as an excipient. Innovations in albumin-based drug formulations and increased research into its potential in advanced therapies offer new growth opportunities.

What are the threats in the Albumin (as Excipient) Market 2025?

Competition from alternative excipients, such as synthetic substitutes and other natural proteins, may pose a challenge to albumin's dominance. Regulatory hurdles, including stringent quality control and testing requirements, could slow down market growth.

What are the political factors affecting the Albumin (as Excipient) Market 2025?

Government regulations on the use of biological excipients in pharmaceutical products can impact the market. Policies related to the approval and manufacturing of biologic drugs influence the demand for albumin as an excipient.

What are the economic factors affecting the Albumin (as Excipient) Market 2025?

The high cost of albumin production, coupled with fluctuations in raw material prices, affects the overall market economics. Economic conditions that influence healthcare budgets, especially in developing regions, can limit the use of expensive excipients like albumin.

What are the social factors affecting the Albumin (as Excipient) Market 2025?

There is increasing awareness and demand for biologic drugs, which fuels the need for albumin-based excipients. Additionally, as more patients opt for personalized and advanced therapies, the demand for efficient excipients like albumin is likely to rise.

What are the technological factors affecting the Albumin (as Excipient) Market 2025?

Advancements in protein purification techniques and recombinant technology have improved the quality and cost-effectiveness of albumin production. The development of more efficient drug delivery systems will increase the demand for albumin as a critical excipient.

What are the environmental factors affecting the Albumin (as Excipient) Market 2025?

Environmental sustainability concerns surrounding the sourcing and production of animal-derived albumin may push for more eco-friendly alternatives. Pressure from environmental regulations could lead to innovations in green manufacturing practices for excipients.

What are the legal factors affecting the Albumin (as Excipient) Market 2025?

Strict regulatory frameworks for biologic drugs and excipient safety standards are a key concern. Legal challenges related to the patenting of albumin-derived products, along with compliance with international standards, will impact market dynamics.

Who are the suppliers in the Albumin (as Excipient) Market 2025?

Suppliers include manufacturers of albumin, which may range from large pharmaceutical companies to specialized firms that focus on protein purification and biotechnological advancements.

What are the inputs in the Albumin (as Excipient) Market 2025?

Inputs involve raw materials such as human or animal plasma, recombinant technology, and advanced protein processing equipment. Additionally, research and development in excipient technologies play a significant role.

What are the processes in the Albumin (as Excipient) Market 2025?

The key processes include the extraction and purification of albumin, quality control, regulatory testing, formulation of drugs with albumin, and compliance with pharmaceutical standards to ensure safety and efficacy.

What are the outputs in the Albumin (as Excipient) Market 2025?

The outputs are biologic drugs, vaccines, and gene therapies that incorporate albumin as an excipient to improve drug delivery, stability, and overall performance of the pharmaceutical product.

Who are the customers in the Albumin (as Excipient) Market 2025?

Customers include pharmaceutical and biotechnology companies that develop biologics, contract manufacturers, and research institutions requiring albumin as a critical excipient in drug formulations.

What is the threat of new entrants in the Albumin (as Excipient) Market 2025?

The threat is relatively low due to the high barriers to entry, such as the complexity of protein purification, regulatory approvals, and the high capital investment required to enter the market.

What is the bargaining power of suppliers in the Albumin (as Excipient) Market 2025?

Suppliers hold moderate bargaining power, as the production of albumin relies on specialized raw materials, such as human or animal plasma. However, advancements in recombinant technology may reduce dependence on traditional suppliers over time.

What is the bargaining power of buyers in the Albumin (as Excipient) Market 2025?

Buyers have moderate bargaining power. While albumin is a critical excipient, alternative excipients and synthetic substitutes are emerging, providing buyers with more choices and potentially reducing dependency on albumin.

What is the threat of substitutes in the Albumin (as Excipient) Market 2025?

The threat of substitutes is moderate, as synthetic excipients and other natural proteins are being developed as alternatives to albumin. However, albumin's unique properties still make it highly sought after in certain drug formulations.

What is the intensity of competitive rivalry in the Albumin (as Excipient) Market 2025?

The intensity of competitive rivalry is moderate. The market has a few established players with strong R&D capabilities, but innovation in recombinant technology and the growing demand for biologics is encouraging competition from both large and small companies.

What are the key raw materials in the Albumin (as Excipient) Market 2025?

The key raw materials include human or animal plasma, recombinant proteins, and specialized reagents for protein purification. These raw materials are critical for the production and purification of albumin.

What are the key suppliers in the Albumin (as Excipient) Market 2025?

Key suppliers are large pharmaceutical companies, biotechnology firms, and specialized protein manufacturers who provide albumin and the necessary technologies for its purification, including recombinant production methods.

What are the technological factors affecting upstream activities in the Albumin (as Excipient) Market 2025?

Advancements in recombinant DNA technology, protein engineering, and purification processes significantly impact upstream activities. Innovations in these areas are helping to reduce costs, improve purity, and increase the efficiency of albumin production.

What are the regulatory factors affecting upstream activities in the Albumin (as Excipient) Market 2025?

Regulatory requirements, such as stringent safety and quality control standards set by health authorities (e.g., FDA, EMA), are crucial in the upstream production of albumin. These regulations ensure that albumin meets the necessary specifications for use in pharmaceutical applications.

What are the challenges in the upstream activities of the Albumin (as Excipient) Market 2025?

Challenges include the high cost and complexity of raw material sourcing (particularly plasma), maintaining quality control during the production process, and complying with regulatory standards. Additionally, the environmental impact of animal-derived albumin is an emerging concern.

What are the key processes in the midstream activities of the Albumin (as Excipient) Market 2025?

The key processes include albumin purification, quality control, formulation development, and packaging. These processes ensure that albumin meets the required standards for use as an excipient in pharmaceutical products.

What are the technological factors affecting the midstream activities in the Albumin (as Excipient) Market 2025?

Technological advancements in protein purification, such as chromatography and filtration techniques, are essential for the midstream production of high-quality albumin. Innovations in formulation technologies also enable more efficient drug delivery systems.

What are the key players in the midstream activities of the Albumin (as Excipient) Market 2025?

Key players include pharmaceutical companies and contract manufacturing organizations (CMOs) involved in the formulation and production of albumin-based excipients. These players also ensure compliance with industry standards and regulations.

What are the challenges in the midstream activities of the Albumin (as Excipient) Market 2025?

Challenges include maintaining consistency and purity of albumin during the purification process, meeting regulatory requirements, and addressing the high cost of production. Managing the supply chain for raw materials, such as plasma, also poses a challenge.

What are the trends in the midstream activities of the Albumin (as Excipient) Market 2025?

Emerging trends include the shift towards recombinant albumin production methods, improved efficiency in the purification process, and the development of novel drug delivery systems utilizing albumin-based excipients.

What are the key activities in the downstream part of the Albumin (as Excipient) Market 2025?

Key activities include the distribution of albumin-based excipients to pharmaceutical manufacturers, ensuring compliance with quality standards, and delivering these excipients as part of drug formulations to end-users, such as hospitals and clinics.

What are the customer segments in the downstream activities of the Albumin (as Excipient) Market 2025?

Customer segments include pharmaceutical companies developing biologic drugs, vaccine manufacturers, and contract research organizations (CROs) that require albumin as a critical excipient for drug formulation and delivery.

What are the challenges in the downstream activities of the Albumin (as Excipient) Market 2025?

Challenges include ensuring the timely and safe delivery of albumin-based products to pharmaceutical manufacturers, managing supply chain disruptions, and dealing with the high cost of albumin, which can affect pricing strategies for end-users.

What are the distribution channels in the downstream activities of the Albumin (as Excipient) Market 2025?

Distribution channels typically involve direct sales to pharmaceutical companies, partnerships with contract manufacturers, and third-party logistics providers ensuring the global reach of albumin-based excipients to healthcare providers and drug developers.

What are the trends in the downstream activities of the Albumin (as Excipient) Market 2025?

Trends include increasing demand for biologics and personalized medicines, which require more specialized excipients like albumin. There is also a growing focus on improving global distribution networks and enhancing collaboration between excipient suppliers and pharmaceutical manufacturers.

Chapter 1, to describe Albumin (as Excipient) product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Albumin (as Excipient), with price, sales, revenue and global market share of Albumin (as Excipient) from 2018 to 2023.
Chapter 3, the Albumin (as Excipient) competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Albumin (as Excipient) breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2018 to 2029.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2018 to 2029.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2022.and Albumin (as Excipient) market forecast, by regions, type and application, with sales and revenue, from 2024 to 2029.
Chapter 12, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War.
Chapter 13, the key raw materials and key suppliers, and industry chain of Albumin (as Excipient).
Chapter 14 and 15, to describe Albumin (as Excipient) sales channel, distributors, customers, research findings and conclusion.

1 Market Overview

   1.1 Product Overview and Scope of Albumin (as Excipient)
   1.2 Market Estimation Caveats and Base Year
   1.3 Market Analysis by Type
       1.3.1 Overview: Global Albumin (as Excipient) Consumption Value by Type: 2018 Versus 2022 Versus 2029
       1.3.2 Human Serum Albumin
       1.3.3 Recombinant Albumin
   1.4 Market Analysis by Application
       1.4.1 Overview: Global Albumin (as Excipient) Consumption Value by Application: 2018 Versus 2022 Versus 2029
       1.4.2 Cell Culture Media
       1.4.3 Medical Supplements
       1.4.4 Therapeutics
   1.5 Global Albumin (as Excipient) Market Size & Forecast
       1.5.1 Global Albumin (as Excipient) Consumption Value (2018 & 2022 & 2029)
       1.5.2 Global Albumin (as Excipient) Sales Quantity (2018-2029)
       1.5.3 Global Albumin (as Excipient) Average Price (2018-2029)

2 Manufacturers Profiles

   2.1 CSL
       2.1.1 CSL Details
       2.1.2 CSL Major Business
       2.1.3 CSL Albumin (as Excipient) Product and Services
       2.1.4 CSL Albumin (as Excipient) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
       2.1.5 CSL Recent Developments/Updates
   2.2 Grifols
       2.2.1 Grifols Details
       2.2.2 Grifols Major Business
       2.2.3 Grifols Albumin (as Excipient) Product and Services
       2.2.4 Grifols Albumin (as Excipient) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
       2.2.5 Grifols Recent Developments/Updates
   2.3 Takeda
       2.3.1 Takeda Details
       2.3.2 Takeda Major Business
       2.3.3 Takeda Albumin (as Excipient) Product and Services
       2.3.4 Takeda Albumin (as Excipient) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
       2.3.5 Takeda Recent Developments/Updates
   2.4 Octapharma
       2.4.1 Octapharma Details
       2.4.2 Octapharma Major Business
       2.4.3 Octapharma Albumin (as Excipient) Product and Services
       2.4.4 Octapharma Albumin (as Excipient) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
       2.4.5 Octapharma Recent Developments/Updates
   2.5 Hualan Bio
       2.5.1 Hualan Bio Details
       2.5.2 Hualan Bio Major Business
       2.5.3 Hualan Bio Albumin (as Excipient) Product and Services
       2.5.4 Hualan Bio Albumin (as Excipient) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
       2.5.5 Hualan Bio Recent Developments/Updates
   2.6 CBPO
       2.6.1 CBPO Details
       2.6.2 CBPO Major Business
       2.6.3 CBPO Albumin (as Excipient) Product and Services
       2.6.4 CBPO Albumin (as Excipient) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
       2.6.5 CBPO Recent Developments/Updates
   2.7 Shanghai RAAS
       2.7.1 Shanghai RAAS Details
       2.7.2 Shanghai RAAS Major Business
       2.7.3 Shanghai RAAS Albumin (as Excipient) Product and Services
       2.7.4 Shanghai RAAS Albumin (as Excipient) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
       2.7.5 Shanghai RAAS Recent Developments/Updates
   2.8 Kedrion
       2.8.1 Kedrion Details
       2.8.2 Kedrion Major Business
       2.8.3 Kedrion Albumin (as Excipient) Product and Services
       2.8.4 Kedrion Albumin (as Excipient) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
       2.8.5 Kedrion Recent Developments/Updates
   2.9 LFB Group
       2.9.1 LFB Group Details
       2.9.2 LFB Group Major Business
       2.9.3 LFB Group Albumin (as Excipient) Product and Services
       2.9.4 LFB Group Albumin (as Excipient) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
       2.9.5 LFB Group Recent Developments/Updates
   2.10 Albumedix
       2.10.1 Albumedix Details
       2.10.2 Albumedix Major Business
       2.10.3 Albumedix Albumin (as Excipient) Product and Services
       2.10.4 Albumedix Albumin (as Excipient) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
       2.10.5 Albumedix Recent Developments/Updates
   2.11 Biotest
       2.11.1 Biotest Details
       2.11.2 Biotest Major Business
       2.11.3 Biotest Albumin (as Excipient) Product and Services
       2.11.4 Biotest Albumin (as Excipient) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
       2.11.5 Biotest Recent Developments/Updates
   2.12 Merck
       2.12.1 Merck Details
       2.12.2 Merck Major Business
       2.12.3 Merck Albumin (as Excipient) Product and Services
       2.12.4 Merck Albumin (as Excipient) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
       2.12.5 Merck Recent Developments/Updates
   2.13 Ventria (InVitria)
       2.13.1 Ventria (InVitria) Details
       2.13.2 Ventria (InVitria) Major Business
       2.13.3 Ventria (InVitria) Albumin (as Excipient) Product and Services
       2.13.4 Ventria (InVitria) Albumin (as Excipient) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
       2.13.5 Ventria (InVitria) Recent Developments/Updates
   2.14 HiMedia
       2.14.1 HiMedia Details
       2.14.2 HiMedia Major Business
       2.14.3 HiMedia Albumin (as Excipient) Product and Services
       2.14.4 HiMedia Albumin (as Excipient) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
       2.14.5 HiMedia Recent Developments/Updates

3 Competitive Environment: Albumin (as Excipient) by Manufacturer

   3.1 Global Albumin (as Excipient) Sales Quantity by Manufacturer (2018-2023)
   3.2 Global Albumin (as Excipient) Revenue by Manufacturer (2018-2023)
   3.3 Global Albumin (as Excipient) Average Price by Manufacturer (2018-2023)
   3.4 Market Share Analysis (2022)
       3.4.1 Producer Shipments of Albumin (as Excipient) by Manufacturer Revenue ($MM) and Market Share (%): 2022
       3.4.2 Top 3 Albumin (as Excipient) Manufacturer Market Share in 2022
       3.4.2 Top 6 Albumin (as Excipient) Manufacturer Market Share in 2022
   3.5 Albumin (as Excipient) Market: Overall Company Footprint Analysis
       3.5.1 Albumin (as Excipient) Market: Region Footprint
       3.5.2 Albumin (as Excipient) Market: Company Product Type Footprint
       3.5.3 Albumin (as Excipient) Market: Company Product Application Footprint
   3.6 New Market Entrants and Barriers to Market Entry
   3.7 Mergers, Acquisition, Agreements, and Collaborations

4 Consumption Analysis by Region

   4.1 Global Albumin (as Excipient) Market Size by Region
       4.1.1 Global Albumin (as Excipient) Sales Quantity by Region (2018-2029)
       4.1.2 Global Albumin (as Excipient) Consumption Value by Region (2018-2029)
       4.1.3 Global Albumin (as Excipient) Average Price by Region (2018-2029)
   4.2 North America Albumin (as Excipient) Consumption Value (2018-2029)
   4.3 Europe Albumin (as Excipient) Consumption Value (2018-2029)
   4.4 Asia-Pacific Albumin (as Excipient) Consumption Value (2018-2029)
   4.5 South America Albumin (as Excipient) Consumption Value (2018-2029)
   4.6 Middle East and Africa Albumin (as Excipient) Consumption Value (2018-2029)

5 Market Segment by Type

   5.1 Global Albumin (as Excipient) Sales Quantity by Type (2018-2029)
   5.2 Global Albumin (as Excipient) Consumption Value by Type (2018-2029)
   5.3 Global Albumin (as Excipient) Average Price by Type (2018-2029)

6 Market Segment by Application

   6.1 Global Albumin (as Excipient) Sales Quantity by Application (2018-2029)
   6.2 Global Albumin (as Excipient) Consumption Value by Application (2018-2029)
   6.3 Global Albumin (as Excipient) Average Price by Application (2018-2029)

7 North America

   7.1 North America Albumin (as Excipient) Sales Quantity by Type (2018-2029)
   7.2 North America Albumin (as Excipient) Sales Quantity by Application (2018-2029)
   7.3 North America Albumin (as Excipient) Market Size by Country
       7.3.1 North America Albumin (as Excipient) Sales Quantity by Country (2018-2029)
       7.3.2 North America Albumin (as Excipient) Consumption Value by Country (2018-2029)
       7.3.3 United States Market Size and Forecast (2018-2029)
       7.3.4 Canada Market Size and Forecast (2018-2029)
       7.3.5 Mexico Market Size and Forecast (2018-2029)

8 Europe

   8.1 Europe Albumin (as Excipient) Sales Quantity by Type (2018-2029)
   8.2 Europe Albumin (as Excipient) Sales Quantity by Application (2018-2029)
   8.3 Europe Albumin (as Excipient) Market Size by Country
       8.3.1 Europe Albumin (as Excipient) Sales Quantity by Country (2018-2029)
       8.3.2 Europe Albumin (as Excipient) Consumption Value by Country (2018-2029)
       8.3.3 Germany Market Size and Forecast (2018-2029)
       8.3.4 France Market Size and Forecast (2018-2029)
       8.3.5 United Kingdom Market Size and Forecast (2018-2029)
       8.3.6 Russia Market Size and Forecast (2018-2029)
       8.3.7 Italy Market Size and Forecast (2018-2029)

9 Asia-Pacific

   9.1 Asia-Pacific Albumin (as Excipient) Sales Quantity by Type (2018-2029)
   9.2 Asia-Pacific Albumin (as Excipient) Sales Quantity by Application (2018-2029)
   9.3 Asia-Pacific Albumin (as Excipient) Market Size by Region
       9.3.1 Asia-Pacific Albumin (as Excipient) Sales Quantity by Region (2018-2029)
       9.3.2 Asia-Pacific Albumin (as Excipient) Consumption Value by Region (2018-2029)
       9.3.3 China Market Size and Forecast (2018-2029)
       9.3.4 Japan Market Size and Forecast (2018-2029)
       9.3.5 Korea Market Size and Forecast (2018-2029)
       9.3.6 India Market Size and Forecast (2018-2029)
       9.3.7 Southeast Asia Market Size and Forecast (2018-2029)
       9.3.8 Australia Market Size and Forecast (2018-2029)

10 South America

   10.1 South America Albumin (as Excipient) Sales Quantity by Type (2018-2029)
   10.2 South America Albumin (as Excipient) Sales Quantity by Application (2018-2029)
   10.3 South America Albumin (as Excipient) Market Size by Country
       10.3.1 South America Albumin (as Excipient) Sales Quantity by Country (2018-2029)
       10.3.2 South America Albumin (as Excipient) Consumption Value by Country (2018-2029)
       10.3.3 Brazil Market Size and Forecast (2018-2029)
       10.3.4 Argentina Market Size and Forecast (2018-2029)

11 Middle East & Africa

   11.1 Middle East & Africa Albumin (as Excipient) Sales Quantity by Type (2018-2029)
   11.2 Middle East & Africa Albumin (as Excipient) Sales Quantity by Application (2018-2029)
   11.3 Middle East & Africa Albumin (as Excipient) Market Size by Country
       11.3.1 Middle East & Africa Albumin (as Excipient) Sales Quantity by Country (2018-2029)
       11.3.2 Middle East & Africa Albumin (as Excipient) Consumption Value by Country (2018-2029)
       11.3.3 Turkey Market Size and Forecast (2018-2029)
       11.3.4 Egypt Market Size and Forecast (2018-2029)
       11.3.5 Saudi Arabia Market Size and Forecast (2018-2029)
       11.3.6 South Africa Market Size and Forecast (2018-2029)

12 Market Dynamics

   12.1 Albumin (as Excipient) Market Drivers
   12.2 Albumin (as Excipient) Market Restraints
   12.3 Albumin (as Excipient) Trends Analysis
   12.4 Porters Five Forces Analysis
       12.4.1 Threat of New Entrants
       12.4.2 Bargaining Power of Suppliers
       12.4.3 Bargaining Power of Buyers
       12.4.4 Threat of Substitutes
       12.4.5 Competitive Rivalry
   12.5 Influence of COVID-19 and Russia-Ukraine War
       12.5.1 Influence of COVID-19
       12.5.2 Influence of Russia-Ukraine War

13 Raw Material and Industry Chain

   13.1 Raw Material of Albumin (as Excipient) and Key Manufacturers
   13.2 Manufacturing Costs Percentage of Albumin (as Excipient)
   13.3 Albumin (as Excipient) Production Process
   13.4 Albumin (as Excipient) Industrial Chain

14 Shipments by Distribution Channel

   14.1 Sales Channel
       14.1.1 Direct to End-User
       14.1.2 Distributors
   14.2 Albumin (as Excipient) Typical Distributors
   14.3 Albumin (as Excipient) Typical Customers

15 Research Findings and Conclusion

16 Appendix

   16.1 Methodology
   16.2 Research Process and Data Source
   16.3 Disclaimer

List of Tables

   Table 1. Global Albumin (as Excipient) Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
   Table 2. Global Albumin (as Excipient) Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
   Table 3. CSL Basic Information, Manufacturing Base and Competitors
   Table 4. CSL Major Business
   Table 5. CSL Albumin (as Excipient) Product and Services
   Table 6. CSL Albumin (as Excipient) Sales Quantity (MT), Average Price (USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
   Table 7. CSL Recent Developments/Updates
   Table 8. Grifols Basic Information, Manufacturing Base and Competitors
   Table 9. Grifols Major Business
   Table 10. Grifols Albumin (as Excipient) Product and Services
   Table 11. Grifols Albumin (as Excipient) Sales Quantity (MT), Average Price (USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
   Table 12. Grifols Recent Developments/Updates
   Table 13. Takeda Basic Information, Manufacturing Base and Competitors
   Table 14. Takeda Major Business
   Table 15. Takeda Albumin (as Excipient) Product and Services
   Table 16. Takeda Albumin (as Excipient) Sales Quantity (MT), Average Price (USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
   Table 17. Takeda Recent Developments/Updates
   Table 18. Octapharma Basic Information, Manufacturing Base and Competitors
   Table 19. Octapharma Major Business
   Table 20. Octapharma Albumin (as Excipient) Product and Services
   Table 21. Octapharma Albumin (as Excipient) Sales Quantity (MT), Average Price (USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
   Table 22. Octapharma Recent Developments/Updates
   Table 23. Hualan Bio Basic Information, Manufacturing Base and Competitors
   Table 24. Hualan Bio Major Business
   Table 25. Hualan Bio Albumin (as Excipient) Product and Services
   Table 26. Hualan Bio Albumin (as Excipient) Sales Quantity (MT), Average Price (USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
   Table 27. Hualan Bio Recent Developments/Updates
   Table 28. CBPO Basic Information, Manufacturing Base and Competitors
   Table 29. CBPO Major Business
   Table 30. CBPO Albumin (as Excipient) Product and Services
   Table 31. CBPO Albumin (as Excipient) Sales Quantity (MT), Average Price (USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
   Table 32. CBPO Recent Developments/Updates
   Table 33. Shanghai RAAS Basic Information, Manufacturing Base and Competitors
   Table 34. Shanghai RAAS Major Business
   Table 35. Shanghai RAAS Albumin (as Excipient) Product and Services
   Table 36. Shanghai RAAS Albumin (as Excipient) Sales Quantity (MT), Average Price (USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
   Table 37. Shanghai RAAS Recent Developments/Updates
   Table 38. Kedrion Basic Information, Manufacturing Base and Competitors
   Table 39. Kedrion Major Business
   Table 40. Kedrion Albumin (as Excipient) Product and Services
   Table 41. Kedrion Albumin (as Excipient) Sales Quantity (MT), Average Price (USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
   Table 42. Kedrion Recent Developments/Updates
   Table 43. LFB Group Basic Information, Manufacturing Base and Competitors
   Table 44. LFB Group Major Business
   Table 45. LFB Group Albumin (as Excipient) Product and Services
   Table 46. LFB Group Albumin (as Excipient) Sales Quantity (MT), Average Price (USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
   Table 47. LFB Group Recent Developments/Updates
   Table 48. Albumedix Basic Information, Manufacturing Base and Competitors
   Table 49. Albumedix Major Business
   Table 50. Albumedix Albumin (as Excipient) Product and Services
   Table 51. Albumedix Albumin (as Excipient) Sales Quantity (MT), Average Price (USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
   Table 52. Albumedix Recent Developments/Updates
   Table 53. Biotest Basic Information, Manufacturing Base and Competitors
   Table 54. Biotest Major Business
   Table 55. Biotest Albumin (as Excipient) Product and Services
   Table 56. Biotest Albumin (as Excipient) Sales Quantity (MT), Average Price (USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
   Table 57. Biotest Recent Developments/Updates
   Table 58. Merck Basic Information, Manufacturing Base and Competitors
   Table 59. Merck Major Business
   Table 60. Merck Albumin (as Excipient) Product and Services
   Table 61. Merck Albumin (as Excipient) Sales Quantity (MT), Average Price (USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
   Table 62. Merck Recent Developments/Updates
   Table 63. Ventria (InVitria) Basic Information, Manufacturing Base and Competitors
   Table 64. Ventria (InVitria) Major Business
   Table 65. Ventria (InVitria) Albumin (as Excipient) Product and Services
   Table 66. Ventria (InVitria) Albumin (as Excipient) Sales Quantity (MT), Average Price (USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
   Table 67. Ventria (InVitria) Recent Developments/Updates
   Table 68. HiMedia Basic Information, Manufacturing Base and Competitors
   Table 69. HiMedia Major Business
   Table 70. HiMedia Albumin (as Excipient) Product and Services
   Table 71. HiMedia Albumin (as Excipient) Sales Quantity (MT), Average Price (USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
   Table 72. HiMedia Recent Developments/Updates
   Table 73. Global Albumin (as Excipient) Sales Quantity by Manufacturer (2018-2023) & (MT)
   Table 74. Global Albumin (as Excipient) Revenue by Manufacturer (2018-2023) & (USD Million)
   Table 75. Global Albumin (as Excipient) Average Price by Manufacturer (2018-2023) & (USD/Kg)
   Table 76. Market Position of Manufacturers in Albumin (as Excipient), (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2022
   Table 77. Head Office and Albumin (as Excipient) Production Site of Key Manufacturer
   Table 78. Albumin (as Excipient) Market: Company Product Type Footprint
   Table 79. Albumin (as Excipient) Market: Company Product Application Footprint
   Table 80. Albumin (as Excipient) New Market Entrants and Barriers to Market Entry
   Table 81. Albumin (as Excipient) Mergers, Acquisition, Agreements, and Collaborations
   Table 82. Global Albumin (as Excipient) Sales Quantity by Region (2018-2023) & (MT)
   Table 83. Global Albumin (as Excipient) Sales Quantity by Region (2024-2029) & (MT)
   Table 84. Global Albumin (as Excipient) Consumption Value by Region (2018-2023) & (USD Million)
   Table 85. Global Albumin (as Excipient) Consumption Value by Region (2024-2029) & (USD Million)
   Table 86. Global Albumin (as Excipient) Average Price by Region (2018-2023) & (USD/Kg)
   Table 87. Global Albumin (as Excipient) Average Price by Region (2024-2029) & (USD/Kg)
   Table 88. Global Albumin (as Excipient) Sales Quantity by Type (2018-2023) & (MT)
   Table 89. Global Albumin (as Excipient) Sales Quantity by Type (2024-2029) & (MT)
   Table 90. Global Albumin (as Excipient) Consumption Value by Type (2018-2023) & (USD Million)
   Table 91. Global Albumin (as Excipient) Consumption Value by Type (2024-2029) & (USD Million)
   Table 92. Global Albumin (as Excipient) Average Price by Type (2018-2023) & (USD/Kg)
   Table 93. Global Albumin (as Excipient) Average Price by Type (2024-2029) & (USD/Kg)
   Table 94. Global Albumin (as Excipient) Sales Quantity by Application (2018-2023) & (MT)
   Table 95. Global Albumin (as Excipient) Sales Quantity by Application (2024-2029) & (MT)
   Table 96. Global Albumin (as Excipient) Consumption Value by Application (2018-2023) & (USD Million)
   Table 97. Global Albumin (as Excipient) Consumption Value by Application (2024-2029) & (USD Million)
   Table 98. Global Albumin (as Excipient) Average Price by Application (2018-2023) & (USD/Kg)
   Table 99. Global Albumin (as Excipient) Average Price by Application (2024-2029) & (USD/Kg)
   Table 100. North America Albumin (as Excipient) Sales Quantity by Type (2018-2023) & (MT)
   Table 101. North America Albumin (as Excipient) Sales Quantity by Type (2024-2029) & (MT)
   Table 102. North America Albumin (as Excipient) Sales Quantity by Application (2018-2023) & (MT)
   Table 103. North America Albumin (as Excipient) Sales Quantity by Application (2024-2029) & (MT)
   Table 104. North America Albumin (as Excipient) Sales Quantity by Country (2018-2023) & (MT)
   Table 105. North America Albumin (as Excipient) Sales Quantity by Country (2024-2029) & (MT)
   Table 106. North America Albumin (as Excipient) Consumption Value by Country (2018-2023) & (USD Million)
   Table 107. North America Albumin (as Excipient) Consumption Value by Country (2024-2029) & (USD Million)
   Table 108. Europe Albumin (as Excipient) Sales Quantity by Type (2018-2023) & (MT)
   Table 109. Europe Albumin (as Excipient) Sales Quantity by Type (2024-2029) & (MT)
   Table 110. Europe Albumin (as Excipient) Sales Quantity by Application (2018-2023) & (MT)
   Table 111. Europe Albumin (as Excipient) Sales Quantity by Application (2024-2029) & (MT)
   Table 112. Europe Albumin (as Excipient) Sales Quantity by Country (2018-2023) & (MT)
   Table 113. Europe Albumin (as Excipient) Sales Quantity by Country (2024-2029) & (MT)
   Table 114. Europe Albumin (as Excipient) Consumption Value by Country (2018-2023) & (USD Million)
   Table 115. Europe Albumin (as Excipient) Consumption Value by Country (2024-2029) & (USD Million)
   Table 116. Asia-Pacific Albumin (as Excipient) Sales Quantity by Type (2018-2023) & (MT)
   Table 117. Asia-Pacific Albumin (as Excipient) Sales Quantity by Type (2024-2029) & (MT)
   Table 118. Asia-Pacific Albumin (as Excipient) Sales Quantity by Application (2018-2023) & (MT)
   Table 119. Asia-Pacific Albumin (as Excipient) Sales Quantity by Application (2024-2029) & (MT)
   Table 120. Asia-Pacific Albumin (as Excipient) Sales Quantity by Region (2018-2023) & (MT)
   Table 121. Asia-Pacific Albumin (as Excipient) Sales Quantity by Region (2024-2029) & (MT)
   Table 122. Asia-Pacific Albumin (as Excipient) Consumption Value by Region (2018-2023) & (USD Million)
   Table 123. Asia-Pacific Albumin (as Excipient) Consumption Value by Region (2024-2029) & (USD Million)
   Table 124. South America Albumin (as Excipient) Sales Quantity by Type (2018-2023) & (MT)
   Table 125. South America Albumin (as Excipient) Sales Quantity by Type (2024-2029) & (MT)
   Table 126. South America Albumin (as Excipient) Sales Quantity by Application (2018-2023) & (MT)
   Table 127. South America Albumin (as Excipient) Sales Quantity by Application (2024-2029) & (MT)
   Table 128. South America Albumin (as Excipient) Sales Quantity by Country (2018-2023) & (MT)
   Table 129. South America Albumin (as Excipient) Sales Quantity by Country (2024-2029) & (MT)
   Table 130. South America Albumin (as Excipient) Consumption Value by Country (2018-2023) & (USD Million)
   Table 131. South America Albumin (as Excipient) Consumption Value by Country (2024-2029) & (USD Million)
   Table 132. Middle East & Africa Albumin (as Excipient) Sales Quantity by Type (2018-2023) & (MT)
   Table 133. Middle East & Africa Albumin (as Excipient) Sales Quantity by Type (2024-2029) & (MT)
   Table 134. Middle East & Africa Albumin (as Excipient) Sales Quantity by Application (2018-2023) & (MT)
   Table 135. Middle East & Africa Albumin (as Excipient) Sales Quantity by Application (2024-2029) & (MT)
   Table 136. Middle East & Africa Albumin (as Excipient) Sales Quantity by Region (2018-2023) & (MT)
   Table 137. Middle East & Africa Albumin (as Excipient) Sales Quantity by Region (2024-2029) & (MT)
   Table 138. Middle East & Africa Albumin (as Excipient) Consumption Value by Region (2018-2023) & (USD Million)
   Table 139. Middle East & Africa Albumin (as Excipient) Consumption Value by Region (2024-2029) & (USD Million)
   Table 140. Albumin (as Excipient) Raw Material
   Table 141. Key Manufacturers of Albumin (as Excipient) Raw Materials
   Table 142. Albumin (as Excipient) Typical Distributors
   Table 143. Albumin (as Excipient) Typical Customers

List of Figures

   Figure 1. Albumin (as Excipient) Picture
   Figure 2. Global Albumin (as Excipient) Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
   Figure 3. Global Albumin (as Excipient) Consumption Value Market Share by Type in 2022
   Figure 4. Human Serum Albumin Examples
   Figure 5. Recombinant Albumin Examples
   Figure 6. Global Albumin (as Excipient) Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
   Figure 7. Global Albumin (as Excipient) Consumption Value Market Share by Application in 2022
   Figure 8. Cell Culture Media Examples
   Figure 9. Medical Supplements Examples
   Figure 10. Therapeutics Examples
   Figure 11. Global Albumin (as Excipient) Consumption Value, (USD Million): 2018 & 2022 & 2029
   Figure 12. Global Albumin (as Excipient) Consumption Value and Forecast (2018-2029) & (USD Million)
   Figure 13. Global Albumin (as Excipient) Sales Quantity (2018-2029) & (MT)
   Figure 14. Global Albumin (as Excipient) Average Price (2018-2029) & (USD/Kg)
   Figure 15. Global Albumin (as Excipient) Sales Quantity Market Share by Manufacturer in 2022
   Figure 16. Global Albumin (as Excipient) Consumption Value Market Share by Manufacturer in 2022
   Figure 17. Producer Shipments of Albumin (as Excipient) by Manufacturer Sales Quantity ($MM) and Market Share (%): 2021
   Figure 18. Top 3 Albumin (as Excipient) Manufacturer (Consumption Value) Market Share in 2022
   Figure 19. Top 6 Albumin (as Excipient) Manufacturer (Consumption Value) Market Share in 2022
   Figure 20. Global Albumin (as Excipient) Sales Quantity Market Share by Region (2018-2029)
   Figure 21. Global Albumin (as Excipient) Consumption Value Market Share by Region (2018-2029)
   Figure 22. North America Albumin (as Excipient) Consumption Value (2018-2029) & (USD Million)
   Figure 23. Europe Albumin (as Excipient) Consumption Value (2018-2029) & (USD Million)
   Figure 24. Asia-Pacific Albumin (as Excipient) Consumption Value (2018-2029) & (USD Million)
   Figure 25. South America Albumin (as Excipient) Consumption Value (2018-2029) & (USD Million)
   Figure 26. Middle East & Africa Albumin (as Excipient) Consumption Value (2018-2029) & (USD Million)
   Figure 27. Global Albumin (as Excipient) Sales Quantity Market Share by Type (2018-2029)
   Figure 28. Global Albumin (as Excipient) Consumption Value Market Share by Type (2018-2029)
   Figure 29. Global Albumin (as Excipient) Average Price by Type (2018-2029) & (USD/Kg)
   Figure 30. Global Albumin (as Excipient) Sales Quantity Market Share by Application (2018-2029)
   Figure 31. Global Albumin (as Excipient) Consumption Value Market Share by Application (2018-2029)
   Figure 32. Global Albumin (as Excipient) Average Price by Application (2018-2029) & (USD/Kg)
   Figure 33. North America Albumin (as Excipient) Sales Quantity Market Share by Type (2018-2029)
   Figure 34. North America Albumin (as Excipient) Sales Quantity Market Share by Application (2018-2029)
   Figure 35. North America Albumin (as Excipient) Sales Quantity Market Share by Country (2018-2029)
   Figure 36. North America Albumin (as Excipient) Consumption Value Market Share by Country (2018-2029)
   Figure 37. United States Albumin (as Excipient) Consumption Value and Growth Rate (2018-2029) & (USD Million)
   Figure 38. Canada Albumin (as Excipient) Consumption Value and Growth Rate (2018-2029) & (USD Million)
   Figure 39. Mexico Albumin (as Excipient) Consumption Value and Growth Rate (2018-2029) & (USD Million)
   Figure 40. Europe Albumin (as Excipient) Sales Quantity Market Share by Type (2018-2029)
   Figure 41. Europe Albumin (as Excipient) Sales Quantity Market Share by Application (2018-2029)
   Figure 42. Europe Albumin (as Excipient) Sales Quantity Market Share by Country (2018-2029)
   Figure 43. Europe Albumin (as Excipient) Consumption Value Market Share by Country (2018-2029)
   Figure 44. Germany Albumin (as Excipient) Consumption Value and Growth Rate (2018-2029) & (USD Million)
   Figure 45. France Albumin (as Excipient) Consumption Value and Growth Rate (2018-2029) & (USD Million)
   Figure 46. United Kingdom Albumin (as Excipient) Consumption Value and Growth Rate (2018-2029) & (USD Million)
   Figure 47. Russia Albumin (as Excipient) Consumption Value and Growth Rate (2018-2029) & (USD Million)
   Figure 48. Italy Albumin (as Excipient) Consumption Value and Growth Rate (2018-2029) & (USD Million)
   Figure 49. Asia-Pacific Albumin (as Excipient) Sales Quantity Market Share by Type (2018-2029)
   Figure 50. Asia-Pacific Albumin (as Excipient) Sales Quantity Market Share by Application (2018-2029)
   Figure 51. Asia-Pacific Albumin (as Excipient) Sales Quantity Market Share by Region (2018-2029)
   Figure 52. Asia-Pacific Albumin (as Excipient) Consumption Value Market Share by Region (2018-2029)
   Figure 53. China Albumin (as Excipient) Consumption Value and Growth Rate (2018-2029) & (USD Million)
   Figure 54. Japan Albumin (as Excipient) Consumption Value and Growth Rate (2018-2029) & (USD Million)
   Figure 55. Korea Albumin (as Excipient) Consumption Value and Growth Rate (2018-2029) & (USD Million)
   Figure 56. India Albumin (as Excipient) Consumption Value and Growth Rate (2018-2029) & (USD Million)
   Figure 57. Southeast Asia Albumin (as Excipient) Consumption Value and Growth Rate (2018-2029) & (USD Million)
   Figure 58. Australia Albumin (as Excipient) Consumption Value and Growth Rate (2018-2029) & (USD Million)
   Figure 59. South America Albumin (as Excipient) Sales Quantity Market Share by Type (2018-2029)
   Figure 60. South America Albumin (as Excipient) Sales Quantity Market Share by Application (2018-2029)
   Figure 61. South America Albumin (as Excipient) Sales Quantity Market Share by Country (2018-2029)
   Figure 62. South America Albumin (as Excipient) Consumption Value Market Share by Country (2018-2029)
   Figure 63. Brazil Albumin (as Excipient) Consumption Value and Growth Rate (2018-2029) & (USD Million)
   Figure 64. Argentina Albumin (as Excipient) Consumption Value and Growth Rate (2018-2029) & (USD Million)
   Figure 65. Middle East & Africa Albumin (as Excipient) Sales Quantity Market Share by Type (2018-2029)
   Figure 66. Middle East & Africa Albumin (as Excipient) Sales Quantity Market Share by Application (2018-2029)
   Figure 67. Middle East & Africa Albumin (as Excipient) Sales Quantity Market Share by Region (2018-2029)
   Figure 68. Middle East & Africa Albumin (as Excipient) Consumption Value Market Share by Region (2018-2029)
   Figure 69. Turkey Albumin (as Excipient) Consumption Value and Growth Rate (2018-2029) & (USD Million)
   Figure 70. Egypt Albumin (as Excipient) Consumption Value and Growth Rate (2018-2029) & (USD Million)
   Figure 71. Saudi Arabia Albumin (as Excipient) Consumption Value and Growth Rate (2018-2029) & (USD Million)
   Figure 72. South Africa Albumin (as Excipient) Consumption Value and Growth Rate (2018-2029) & (USD Million)
   Figure 73. Albumin (as Excipient) Market Drivers
   Figure 74. Albumin (as Excipient) Market Restraints
   Figure 75. Albumin (as Excipient) Market Trends
   Figure 76. Porters Five Forces Analysis
   Figure 77. Manufacturing Cost Structure Analysis of Albumin (as Excipient) in 2022
   Figure 78. Manufacturing Process Analysis of Albumin (as Excipient)
   Figure 79. Albumin (as Excipient) Industrial Chain
   Figure 80. Sales Quantity Channel: Direct to End-User vs Distributors
   Figure 81. Direct Channel Pros & Cons
   Figure 82. Indirect Channel Pros & Cons
   Figure 83. Methodology
   Figure 84. Research Process and Data Source